ANTHEM Fracture System
GLOBUS MEDICAL, INC. · Decision date Oct 23, 2026
What did the FDA decide?
Globus Medical, Inc. received a substantially equivalent (SESE) decision for the ANTHEM™ Fracture System under 510(k) K262779, with a decision date of October 23, 2026 and a receipt date of August 5, 2026. The submission is a traditional 510(k) reviewed by FDA rather than a third party, classified under 21 CFR 888.3030 (bone fixation plate) with primary product code HRS and subsequent code HWC, in the orthopedic specialty. SESE is a clearance finding, not premarket approval.
The 510(k) summary describes the submission as a line extension covering ANTHEM® Large Fragment plates, Periprosthetic plates, and screws added to the existing ANTHEM™ Fracture System, which comprises plates, screws, and washers for internal bone fixation in titanium alloy, stainless steel, or cobalt chromium molybdenum alloy. The summary lists the ANTHEM™ Fracture System (K213591) as primary predicate with additional predicates including K163361, K202496, K100111, K120772, K210205, K203405, K082807, K092609, and K001709. Performance support was engineering analysis of static torsion, driving torque, and axial pullout for screws; no clinical outcome data are reported in the provided excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262779
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- GLOBUS MEDICAL, INC.
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- GLOBUS MEDICAL, INC.
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K262779 received
Application receipt date recorded by FDA.
K262779 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| ARTHREX, INC. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Skeletal Dynamics, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
Park's Pectus SystemK263269 | Tdm Co., Ltd. | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GLOBUS MEDICAL, INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Audubon, PA
Sources and methodology
- Original FDA record: K262779
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

